haloperidol has been researched along with loxapine in 50 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 23 (46.00) | 18.7374 |
| 1990's | 12 (24.00) | 18.2507 |
| 2000's | 7 (14.00) | 29.6817 |
| 2010's | 8 (16.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choudhary, MS; Craigo, SC; Meltzer, HY; Monsma, FJ; Roth, BL; Shen, Y; Sibley, DR; Uluer, A | 1 |
| Bartoszyk, GD; Böttcher, H; Liao, Y; Meier, E; Rodenhuis, N; Seyfried, CA; Sundell, S; Timmerman, W; Venhuis, BJ; Wikström, H | 1 |
| Ernsberger, P; Hufeisen, SJ; Jayathilake, K; Kroeze, WK; Meltzer, HY; Popadak, BA; Renock, SM; Roth, BL; Steinberg, S | 1 |
| Glennon, RA | 1 |
| Butini, S; Cagnotto, A; Campiani, G; Carli, M; Carminati, P; Castorina, M; Catalanotti, B; Di Cesare, MA; Di Serio, S; Fattorusso, C; Galletti, B; Gemma, S; Ghirardi, O; Mastroianni, D; Mennini, T; Mereghetti, I; Minetti, P; Morelli, E; Nacci, V; Pacifici, L; Scafetta, N; Stasi, MA; Tinti, O; Vertechy, M | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Ahman, M; Holmén, AG; Wan, H | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Dalvie, D; Loi, CM; Smith, DA | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Bennis, K; Ducki, S; Lesage, F; Vivier, D | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Paprocki, J; Versiani, M | 1 |
| Avery, GS; Brogden, RN; Heel, RC; Speight, TM | 1 |
| Doss, FW | 1 |
| Fruensgaard, K; Jensen, K; Jorgensen, H; Korsgaard, S | 1 |
| Coupet, J; Rauh, CE | 1 |
| Andrade, NM; Barcala Peixoto, MP; Paprocki, J | 1 |
| Glötzner, FL; Mattke, DJ; Mombour, W | 1 |
| Bloom, W; Gallant, DM; Mielke, DH; Pool, D; Roniger, JJ | 1 |
| Helwig, H; McClure, RF; Selman, FB | 1 |
| Mattke, DJ; Wisuschil, W | 1 |
| Asper, H; Bürki, HR; Ruch, W; Sayers, AC | 1 |
| Fliege, K; Kockott, G; Mombour, W | 1 |
| Asper, H; Bürki, HR; Ruch, W | 1 |
| Buckland, PR; McGuffin, P; O'Donovan, MC | 3 |
| Alphs, LD; Kwon, KY; Lee, HS; Meltzer, HY | 1 |
| Banay-Schwartz, M; Cohen, CG; Deutsch, SI; Leighton, M; Rosse, RB; Scarcella, E; Theut, SK | 1 |
| Fuller, MA; Sajatovic, M | 1 |
| Andree, TH; Koenig, JI; Meltzer, HY; Mikuni, M; Tong, CY | 1 |
| Bowden, CL; Contreras, SA; Maas, JW; Seleshi, E | 1 |
| Tuason, VB | 1 |
| Michael, RP; Schaefer, GJ | 2 |
| Davis, KL; Kendler, KS | 1 |
| Lee, T; Tang, SW | 1 |
| Ban, TA; Berney, S; Fujimori, M; Guy, W; Petrie, WM; Ragheb, M; Schaffer, JD; Wilson, WH | 1 |
| Brown, ES; Lambert, MT | 1 |
| Ancill, RJ; Carlyle, W; Sheldon, L | 1 |
| Baskys, A; Remington, G; Wang, S; Wojtowicz, JM | 1 |
| Sunderland, T | 1 |
| Kapur, S; Remington, G | 1 |
| McAllister, KH; Rey, B | 1 |
| Goudie, AJ; Smith, JA | 1 |
| Askenazy, F; Benoit, M; Dor, E; Dupuis, G; Myquel, M; Seddiki, Y; Serret, S | 1 |
| Dold, M; Leucht, S; Li, C; Samara, MT; Tardy, M | 1 |
| Chen, RA; Huang, TL | 1 |
| Cole, JB; Driver, BE; Klein, LR; Mullinax, SZ; Nordstrom, KD; Wilson, MP | 1 |
7 review(s) available for haloperidol and loxapine
| Article | Year |
|---|---|
Higher-end serotonin receptors: 5-HT(5), 5-HT(6), and 5-HT(7).
Topics: Animals; Humans; Ligands; Receptors, Serotonin; Serotonin Agents; Serotonin Antagonists; Serotonin Receptor Agonists | 2003 |
Perspectives on the Two-Pore Domain Potassium Channel TREK-1 (TWIK-Related K(+) Channel 1). A Novel Therapeutic Target?
Topics: Arrhythmias, Cardiac; Depression; Epilepsy; Humans; Inflammation; Models, Molecular; Molecular Structure; Neuroprotective Agents; Pain; Potassium Channels, Tandem Pore Domain; Structure-Activity Relationship | 2016 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Loxapine: a review of its pharmacological properties and therapeutic efficacy as an antipsychotic agent.
Topics: Animals; Anti-Anxiety Agents; Antipsychotic Agents; Chlorpromazine; Dibenzoxazepines; Drug Interactions; Haloperidol; Humans; Intestinal Absorption; Kinetics; Loxapine; Receptors, Dopamine; Schizophrenia; Thiothixene; Trifluoperazine | 1978 |
Treatment of the elderly suffering from psychosis and dementia.
Topics: Age Factors; Aged; Alzheimer Disease; Antipsychotic Agents; Buspirone; Clinical Trials as Topic; Dementia; Drug Administration Schedule; Haloperidol; Humans; Loxapine; Nursing Homes; Psychotic Disorders | 1996 |
D2 and 5-HT2 receptor effects of antipsychotics: bridging basic and clinical findings using PET.
Topics: Amoxapine; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Dopamine Antagonists; Haloperidol; Humans; In Vitro Techniques; Loxapine; Olanzapine; Pirenzepine; Quetiapine Fumarate; Receptors, Dopamine; Receptors, Serotonin; Risperidone; Schizophrenia; Serotonin Antagonists; Tomography, Emission-Computed | 1999 |
Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorders.
Topics: Administration, Oral; Antipsychotic Agents; Haloperidol; Humans; Loxapine; Psychotic Disorders; Randomized Controlled Trials as Topic; Schizophrenia; Trifluoperazine | 2015 |
11 trial(s) available for haloperidol and loxapine
| Article | Year |
|---|---|
A double-blind comparison between loxapine and haloperidol by parenteral route in acute schizophrenia.
Topics: Acute Disease; Adolescent; Adult; Aggression; Brief Psychiatric Rating Scale; Clinical Trials as Topic; Dibenzoxazepines; Drug Evaluation; Female; Haloperidol; Humans; Injections, Intramuscular; Loxapine; Psychiatric Status Rating Scales; Schizophrenia; Sleep; Time Factors | 1977 |
Loxapine versus haloperidol parenterally in acute psychosis with agitation. A double-blind study.
Topics: Acute Disease; Adult; Aged; Aggression; Biperiden; Clinical Trials as Topic; Dibenzoxazepines; Double-Blind Method; Female; Haloperidol; Humans; Injections, Intramuscular; Loxapine; Male; Middle Aged; Psychiatric Status Rating Scales; Psychomotor Agitation; Psychotic Disorders; Schizophrenia; Sleep; Wakefulness | 1977 |
A controlled double-blind comparison between loxapine and haloperidol in acute newly hospitalized schizophrenic patients.
Topics: Acute Disease; Clinical Trials as Topic; Dibenzoxazepines; Haloperidol; Humans; Loxapine; Schizophrenia | 1976 |
[The assessment of neuroleptogenic extrapyramidal syndroms in psychopharmacological research (author's transl)].
Topics: Adult; Basal Ganglia Diseases; Clinical Trials as Topic; Dibenzoxazepines; Female; Haloperidol; Humans; Loxapine; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia | 1975 |
A controlled evaluation of loxitane in seventy-five adolescent schizophrenic patients.
Topics: Adolescent; Clinical Trials as Topic; Dibenzoxazepines; Drug Evaluation; Female; Haloperidol; Humans; Loxapine; Male; Schizophrenia | 1976 |
Loxapine succinate: a double-blind comparison with haloperidol and placebo in acute schizophrenics.
Topics: Acute Disease; Adolescent; Adult; Clinical Trials as Topic; Dibenzoxazepines; Female; Haloperidol; Humans; Loxapine; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Time Factors | 1976 |
[A method for studying pupilomotorics under the influence of neurolepic medication (author's transl)].
Topics: Adult; Constriction; Female; Haloperidol; Humans; Loxapine; Male; Photography; Pupil; Tranquilizing Agents | 1976 |
Urine and plasma levels of dopamine metabolites in response to apomorphine and neuroleptics in schizophrenics.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Apomorphine; Chronic Disease; Clinical Trials as Topic; Dibenzoxazepines; Dopamine; Double-Blind Method; Female; Haloperidol; Homovanillic Acid; Humans; Loxapine; Male; Random Allocation; Schizophrenia | 1988 |
A comparison of parenteral loxapine and haloperidol in hostile and aggressive acutely schizophrenic patients.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Aggression; Clinical Trials as Topic; Dibenzoxazepines; Double-Blind Method; Female; Haloperidol; Hostility; Humans; Injections, Intramuscular; Loxapine; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology | 1986 |
Loxapine in psychogeriatrics: a placebo- and standard-controlled clinical investigation.
Topics: Aged; Clinical Trials as Topic; Dementia; Dibenzoxazepines; Double-Blind Method; Female; Haloperidol; Humans; Loxapine; Male; Middle Aged; Placebos | 1982 |
Aggression in the demented patient: a double-blind study of loxapine versus haloperidol.
Topics: Aged; Aged, 80 and over; Aggression; Alzheimer Disease; Basal Ganglia Diseases; Dementia; Dementia, Multi-Infarct; Double-Blind Method; Female; Haloperidol; Humans; Loxapine; Male | 1993 |
32 other study(ies) available for haloperidol and loxapine
| Article | Year |
|---|---|
Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors.
Topics: Animals; Antipsychotic Agents; Cell Line; Molecular Structure; Rats; Receptors, Serotonin | 1994 |
New (sulfonyloxy)piperazinyldibenzazepines as potential atypical antipsychotics: chemistry and pharmacological evaluation.
Topics: Animals; Antipsychotic Agents; Benzazepines; Brain; Catalepsy; CHO Cells; Cricetinae; Dopamine Antagonists; Humans; In Vitro Techniques; Male; Mice; Molecular Structure; Piperazines; Rats; Rats, Wistar; Receptor, Muscarinic M1; Receptors, Adrenergic, alpha; Receptors, Dopamine; Receptors, Histamine H1; Receptors, Muscarinic; Receptors, Serotonin; Structure-Activity Relationship | 1999 |
H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs.
Topics: Animals; Antipsychotic Agents; Discriminant Analysis; Drug Evaluation, Preclinical; Forecasting; Humans; Protein Binding; Receptors, Histamine H1; Statistics, Nonparametric; Weight Gain | 2003 |
Pyrrolo[1,3]benzothiazepine-based serotonin and dopamine receptor antagonists. Molecular modeling, further structure-activity relationship studies, and identification of novel atypical antipsychotic agents.
Topics: Animals; Antipsychotic Agents; Avoidance Learning; Benzothiepins; Catalepsy; Cognition Disorders; Dopamine Antagonists; Humans; Male; Mice; Models, Molecular; Motor Activity; Pituitary Gland, Anterior; Prolactin; Pyrroles; Rats; Rats, Inbred F344; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Serotonin, 5-HT2; Serotonin Antagonists; Structure-Activity Relationship; Thiazepines | 2004 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs.
Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry | 2009 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Which metabolites circulate?
Topics: Humans; Metabolic Clearance Rate; Pharmaceutical Preparations | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
The effect of antipsychotic drugs on body weight: a retrospective review.
Topics: Antipsychotic Agents; Body Weight; Fluphenazine; Haloperidol; Humans; Loxapine; Schizophrenia; Thioridazine; Thiothixene | 1979 |
3H-Spiroperidol binding to dopamine receptors in rat striatal membranes: influence of loxapine and its hydroxylated metabolites.
Topics: Animals; Butyrophenones; Chlorpromazine; Clozapine; Corpus Striatum; Dibenzoxazepines; Haloperidol; Hydroxylation; In Vitro Techniques; Loxapine; Membranes; Rats; Receptors, Dopamine; Spiperone | 1979 |
Neuroleptic-induced hypersensitivity of striatal dopamine receptors in the rat as a model of tardive dyskinesias. Effects of clozapine, haloperidol, loxapine and chlorpromazine.
Topics: Animals; Apomorphine; Chlorpromazine; Clozapine; Corpus Striatum; Dibenzazepines; Dibenzoxazepines; Disease Models, Animal; Dopamine; Drug Tolerance; Female; Haloperidol; Homovanillic Acid; Humans; Loxapine; Male; Movement Disorders; Rats; Receptors, Drug; Stereotyped Behavior; Substance Withdrawal Syndrome | 1975 |
[The use of the brief psychiatric rating scale (BPRS) by overall and gorham for the diagnosis of acute paranoid psychoses: evaluation of a german translation of the BPRS (author's transl)].
Topics: Acute Disease; Germany, West; Haloperidol; Humans; Loxapine; Schizophrenia, Paranoid | 1975 |
Effect of clozapine on the metabolism of serotonin in rat brain.
Topics: Animals; Brain; Brain Stem; Clozapine; Dibenzazepines; Haloperidol; Hydroxyindoleacetic Acid; Limbic System; Loxapine; Male; Rats; Serotonin; Thioridazine; Tryptophan; Tryptophan Hydroxylase | 1976 |
Changes in dopamine D1, D2 and D3 receptor mRNA levels in rat brain following antipsychotic treatment.
Topics: Animals; Antipsychotic Agents; Blotting, Northern; Brain Chemistry; Haloperidol; Loxapine; Male; Oligonucleotides; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3; RNA, Messenger; Sulpiride | 1992 |
Lack of effect of chronic antipsychotic treatment on dopamine D5 receptor mRNA level.
Topics: Animals; Antipsychotic Agents; Base Sequence; Brain Chemistry; Down-Regulation; Haloperidol; Loxapine; Male; Molecular Sequence Data; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D5; RNA, Messenger; Sulpiride | 1992 |
Effect of clozapine on psychogenic polydipsia in chronic schizophrenia.
Topics: Adult; Clozapine; Drinking; Haloperidol; Humans; Loxapine; Male; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Thirst | 1991 |
Glycine adjuvant therapy to conventional neuroleptic treatment in schizophrenia: an open-label, pilot study.
Topics: Adjuvants, Pharmaceutic; Adult; Aged; Basal Ganglia Diseases; Benztropine; Chronic Disease; Cognition; Drug Therapy, Combination; Glycine; Haloperidol; Humans; Loxapine; Male; Pilot Projects; Schizophrenia; Thiothixene; Vitamin E | 1989 |
Neurotoxicity resulting from a combination of lithium and loxapine.
Topics: Adult; Delirium; Dibenzoxazepines; Drug Therapy, Combination; Haloperidol; Humans; Lithium; Loxapine; Male; Psychoses, Substance-Induced; Schizophrenia, Paranoid | 1989 |
Differential effect of subchronic treatment with various neuroleptic agents on serotonin2 receptors in rat cerebral cortex.
Topics: 5,7-Dihydroxytryptamine; Animals; Antipsychotic Agents; Cerebral Cortex; Chlorpromazine; Clozapine; Female; Haloperidol; Imipramine; Ketanserin; Loxapine; Male; Piperidines; Rats; Rats, Inbred Strains; Receptors, Serotonin; Serotonin; Spiperone; Sulpiride | 1986 |
Acute effects of neuroleptics on brain self-stimulation thresholds in rats.
Topics: Animals; Antipsychotic Agents; Brain; Chlorpromazine; Clozapine; Haloperidol; Loxapine; Male; Pimozide; Rats; Self Stimulation | 1980 |
Drug interactions on spontaneous locomotor activity in rats. Neuroleptics and amphetamine-induced hyperactivity.
Topics: Animals; Antipsychotic Agents; Dextroamphetamine; Drug Interactions; Female; Haloperidol; Loxapine; Molindone; Motor Activity; Pimozide; Rats; Thiothixene | 1984 |
Acute and chronic effects of neuroleptic drugs on plasma and brain homovanillic acid in the rat.
Topics: Animals; Antipsychotic Agents; Brain Chemistry; Chlorpromazine; Fluphenazine; Haloperidol; Homovanillic Acid; Loxapine; Male; Metoclopramide; Molindone; Phenylacetates; Rats; Rats, Inbred Strains; Sulpiride | 1984 |
Loxapine and clozapine decrease serotonin (S2) but do not elevate dopamine (D2) receptor numbers in the rat brain.
Topics: Animals; Clozapine; Dibenzazepines; Dibenzoxazepines; Haloperidol; Loxapine; Male; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Serotonin; Sulpiride; Time Factors | 1984 |
Delusional electronic dental implant: case reports and literature review.
Topics: Adult; Anti-Anxiety Agents; Antipsychotic Agents; Delusions; Dental Implants; Drug Therapy, Combination; Electronics; Haloperidol; Humans; Lorazepam; Loxapine; Male; Middle Aged | 1995 |
Both splicing variants of the dopamine D2 receptor mRNA are up-regulated by antipsychotic drugs.
Topics: Alternative Splicing; Analysis of Variance; Animals; Base Sequence; Brain; Genetic Variation; Haloperidol; Loxapine; Male; Molecular Sequence Data; Oligonucleotide Probes; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; RNA, Messenger; Time Factors; Up-Regulation | 1993 |
Haloperidol and loxapine but not clozapine increase synaptic responses in the hippocampus.
Topics: Animals; Clozapine; Haloperidol; Hippocampus; In Vitro Techniques; Loxapine; Rats; Rats, Wistar; Synapses; Tranquilizing Agents | 1993 |
Clozapine reversal of the deficits in coordinated movement induced by D2 receptor blockade does not depend upon antagonism of alpha2 adrenoceptors.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Ataxia; Clozapine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Haloperidol; Idazoxan; Loxapine; Male; Muscarinic Antagonists; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Scopolamine; Yohimbine | 1999 |
Discriminative stimulus properties in rats of the novel antipsychotic quetiapine.
Topics: Amisulpride; Analysis of Variance; Animals; Antipsychotic Agents; Chlorpromazine; Clozapine; Dibenzothiazepines; Discrimination Learning; Discrimination, Psychological; Dose-Response Relationship, Drug; Female; Generalization, Psychological; Haloperidol; Loxapine; Quetiapine Fumarate; Quinoxalines; Rats; Rats, Wistar; Risperidone; Sulpiride | 2002 |
[Catatonia in a 14 year-old girl: treatment with clorazepam and carbamazepine, a 10-year follow-up].
Topics: Acute Disease; Adolescent; Adult; Anticonvulsants; Antipsychotic Agents; Carbamazepine; Cataplexy; Catatonia; Clonazepam; Combined Modality Therapy; Critical Care; Drug Therapy, Combination; Female; Follow-Up Studies; Haloperidol; Humans; Infusions, Intravenous; Loxapine; Neuroleptic Malignant Syndrome; Psychotic Disorders; Social Adjustment; Young Adult | 2010 |
Periodic catatonia with long-term treatment: a case report.
Topics: Antipsychotic Agents; Catatonia; Clozapine; Drug Therapy, Combination; Female; Haloperidol; Humans; Loxapine; Middle Aged; Risperidone; Schizophrenia | 2017 |
Study Enrollment When "Preconsent" Is Utilized for a Randomized Clinical Trial of Two Treatments for Acute Agitation in the Emergency Department.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Emergency Service, Hospital; Ethics, Research; Female; Haloperidol; Humans; Informed Consent; Lorazepam; Loxapine; Male; Middle Aged; Patient Selection; Psychomotor Agitation; Randomized Controlled Trials as Topic; Schizophrenia | 2019 |